Cargando…
iPSCs: A Preclinical Drug Research Tool for Neurological Disorders
The development and commercialization of new drugs is an articulated, lengthy, and very expensive process that proceeds through several steps, starting from target identification, screening new leading compounds for testing in preclinical studies, and subsequently in clinical trials to reach the fin...
Autores principales: | Bonaventura, Gabriele, Iemmolo, Rosario, Attaguile, Giuseppe Antonino, La Cognata, Valentina, Pistone, Brigida Sabrina, Raudino, Giuseppe, D’Agata, Velia, Cantarella, Giuseppina, Barcellona, Maria Luisa, Cavallaro, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123805/ https://www.ncbi.nlm.nih.gov/pubmed/33925625 http://dx.doi.org/10.3390/ijms22094596 |
Ejemplares similares
-
Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
por: Bonaventura, Gabriele, et al.
Publicado: (2021) -
Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene
por: Cognata, Valentina La, et al.
Publicado: (2014) -
NeuroArray, A Custom CGH Microarray to Decipher Copy Number Variants in Alzheimer’s Disease
por: Cuccaro, Denis, et al.
Publicado: (2018) -
Effect of a Bone Marrow-Derived Extracellular Matrix on Cell Adhesion and Neural Induction of Dental Pulp Stem Cells
por: Laudani, Samuele, et al.
Publicado: (2020) -
Splicing: is there an alternative contribution to Parkinson’s disease?
por: La Cognata, Valentina, et al.
Publicado: (2015)